|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar
|
|
2
|
Baylin SB, Herman JG, Graff JR, Vertino PM
and Issa JP: Alterations in DNA methylation: a fundamental aspect
of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dulaimi E, Hillinck J, Ibanez de Caceres
I, Al-Saleem T and Cairns P: Tumor suppressor gene promoter
hypermethylation in serum of breast cancer patients. Clin Cancer
Res. 10:6189–6193. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leonhardt H and Cardoso MC: DNA
methylation, nuclear structure, gene expression and cancer. J Cell
Biochem Suppl. 35:78–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamashita K, Upadhyay S, Osada M, et al:
Pharmacologic unmasking of epigenetically silenced tumor suppressor
genes in esophageal squamous cell carcinoma. Cancer Cell.
2:485–495. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bennett KL, Karpenko M, Lin MT, et al:
Frequently methylated tumor suppressor genes in head and neck
squamous cell carcinoma. Cancer Res. 68:4494–4499. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bennett KL, Lee W, Lamarre E, et al: HPV
status-independent association of alcohol and tobacco exposure or
prior radiation therapy with promoter methylation of
FUSSEL18, EBF3, IRX1, and SEPT9, but
not SLC5A8, in head and neck squamous cell carcinomas. Genes
Chromosomes Cancer. 49:319–326. 2010.PubMed/NCBI
|
|
9
|
Estécio MR, Youssef EM, Rahal P, et al:
LHX6 is a sensitive methylation marker in head and neck carcinomas.
Oncogene. 25:5018–5026. 2006.PubMed/NCBI
|
|
10
|
Pierconti F, Martini M, Pinto F, et al:
Epigenetic silencing of SOCS3 identifies a subset of
prostate cancer with an aggressive behavior. Prostate. 71:318–325.
2011.
|
|
11
|
Isomoto H: Epigenetic alterations in
cholangiocarcinoma-sustained IL-6/STAT3 signaling in cholangio-
carcinoma due to SOCS3 epigenetic silencing. Digestion. 79(Suppl
1): 2–8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fourouclas N, Li J, Gilby DC, et al:
Methylation of the suppressor of cytokine signaling 3 gene
(SOCS3) in myeloproliferative disorders. Haematologica.
93:1635–1644. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martini M, Pallini R, Luongo G, Cenci T,
Lucantoni C and Larocca LM: Prognostic relevance of SOCS3
hypermethylation in patients with glioblastoma multiforme. Int J
Cancer. 123:2955–2960. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weber A, Hengge UR, Bardenheuer W, et al:
SOCS-3 is frequently methylated in head and neck squamous cell
carcinoma and its precursor lesions and causes growth inhibition.
Oncogene. 24:6699–6708. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thangaraju M, Gopal E, Martin PM, Ananth
S, Smith SB, Prasad PD, Sterneck E and Ganapathy V: SLC5A8 triggers
tumor cell apoptosis through pyruvate-dependent inhibition of
histone deacetylases. Cancer Res. 66:11560–11564. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao LY, Niu Y, Santiago A, Liu J, Albert
SH, Robertson KD and Liao D: An EBF3-mediated transcriptional
program that induces cell cycle arrest and apoptosis. Cancer Res.
66:9445–9452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu YY, Ji J, Lu Y, Bu L, Liu BY, Zhu ZG
and Lin YZ: High-resolution analysis of chromosome 5 and
identification of candidate genes in gastric cancer. Zhonghua Zhong
Liu Za Zhi. 28:84–87. 2006.(In Chinese).
|
|
18
|
Jönsson G, Staaf J, Olsson E, et al:
High-resolution genomic profiles of breast cancer cell lines
assessed by tiling BAC array comparative genomic hybridization.
Genes Chromosomes Cancer. 46:543–558. 2007.PubMed/NCBI
|
|
19
|
Burrows JF, Chanduloy S, McIlhatton MA, et
al: Altered expression of the septin gene, SEPT9, in ovarian
neoplasia. J Pathol. 201:581–588. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Amir S, Wang R, Matzkin H, Simons JW and
Mabjeesh NJ: MSF-A interacts with hypoxia-inducible factor-1α and
augments hypoxia-inducible factor transcriptional activation to
affect tumorigenicity and angiogenesis. Cancer Res. 66:856–866.
2006.PubMed/NCBI
|
|
21
|
Endo S, Zeng Q, Burke NA, et al: TGF-α
antisense gene therapy inhibits head and neck squamous cell
carcinoma growth in vivo. Gene Ther. 7:1906–1914. 2000.
|
|
22
|
Le QT, Kong C, Lavori PW, et al:
Expression and prognostic significance of a panel of tissue hypoxia
markers in head-and-neck squamous cell carcinomas. Int J Radiat
Oncol Biol Phys. 69:167–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sánchez-Elsner T, Botella LM, Velasco B,
Corbí A, Attisano L and Bernabéu C: Synergistic cooperation between
hypoxia and transforming growth factor-β pathways on human vascular
endothelial growth factor gene expression. J Biol Chem.
276:38527–38535. 2001.PubMed/NCBI
|
|
24
|
Bernard PS and Wittwer CT: Real-time PCR
technology for cancer diagnostics. Clin Chem. 48:1178–1185.
2002.PubMed/NCBI
|
|
25
|
Eads CA, Danenberg KD, Kawakami K, et al:
MethyLight: a high-throughput assay to measure DNA methylation.
Nucleic Acids Res. 28:E322000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cottrell SE and Laird PW: Sensitive
detection of DNA methylation. Ann NY Acad Sci. 983:120–130. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jerónimo C, Usadel H, Henrique R, Oliveira
J, Lopes C, Nelson WG and Sidransky D: Quantitation of GSTP1
methylation in non-neoplastic prostatic tissue and organ-confined
prostate adenocarcinoma. J Natl Cancer Inst. 93:1747–1752.
2001.PubMed/NCBI
|
|
28
|
Tokumaru Y, Yamashita K, Osada M, et al:
Inverse correlation between cyclin A1 hypermethylation and p53
mutation in head and neck cancer identified by reversal of
epigenetic silencing. Cancer Res. 64:5982–5987. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li LC and Dahiya R: MethPrimer: designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park HL, Kim MS, Yamashita K, et al: DCC
promoter hypermethylation in esophageal squamous cell carcinoma.
Int J Cancer. 122:2498–2502. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ueki N, Kondo M, Seki N, Yano K, Oda T,
Masuho Y and Muramatsu M: NOLP: identification of a novel human
nucleolar protein and determination of sequence requirements for
its nucleolar localization. Biochem Biophys Res Commun. 252:97–102.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang SS, Smiraglia DJ, Wu YZ, et al:
Identification of novel methylation markers in cervical cancer
using restriction landmark genomic scanning. Cancer Res.
68:2489–2497. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo X, Liu W, Pan Y, et al: Homeobox gene
IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene.
29:3908–3920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bennett KL, Romigh T and Eng C: Disruption
of transforming growth factor-β signaling by five frequently
methylated genes leads to head and neck squamous cell carcinoma
pathogenesis. Cancer Res. 69:9301–9305. 2009.
|
|
35
|
Demokan S, Chuang AY, Chang X, et al:
Identification of guanine nucleotide-binding protein γ-7 as an
epigenetically silenced gene in head and neck cancer by gene
expression profiling. Int J Oncol. 42:1427–1436. 2013.
|
